Skip to main content

A model to estimate the provider cost savings of switching to long acting cytokines for anemia and neutropenia in patients undergoing chemotherapy treatment.

Publication ,  Conference
Glaspy, JA; Meehan, K; Lu, ZJ; Ansari, RH; Brown, R; Erder, MH; Kallich, J; Lee, H; Lyman, GH
Published in: BLOOD
2002

Duke Scholars

Published In

BLOOD

ISSN

0006-4971

Publication Date

2002

Volume

100

Issue

11

Start / End Page

500B / 500B

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Glaspy, J. A., Meehan, K., Lu, Z. J., Ansari, R. H., Brown, R., Erder, M. H., … Lyman, G. H. (2002). A model to estimate the provider cost savings of switching to long acting cytokines for anemia and neutropenia in patients undergoing chemotherapy treatment. In BLOOD (Vol. 100, pp. 500B-500B).
Glaspy, J. A., K. Meehan, Z. J. Lu, R. H. Ansari, R. Brown, M. H. Erder, J. Kallich, H. Lee, and G. H. Lyman. “A model to estimate the provider cost savings of switching to long acting cytokines for anemia and neutropenia in patients undergoing chemotherapy treatment.” In BLOOD, 100:500B-500B, 2002.
Glaspy JA, Meehan K, Lu ZJ, Ansari RH, Brown R, Erder MH, Kallich J, Lee H, Lyman GH. A model to estimate the provider cost savings of switching to long acting cytokines for anemia and neutropenia in patients undergoing chemotherapy treatment. BLOOD. 2002. p. 500B-500B.

Published In

BLOOD

ISSN

0006-4971

Publication Date

2002

Volume

100

Issue

11

Start / End Page

500B / 500B

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology